Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by skyplton Sep 21, 2020 2:26pm
153 Views
Post# 31592072

RE:RE:RE:Retail Perspective

RE:RE:RE:Retail Perspective Thanks for keeping the board up to date on your orders.  It is useful boots on the ground insight.  I remember when Canadian Airlines was going bankrupt.  Air Canada cut a deal with the government (tax breaks, other concessions) and bought Canadian just before it fell under the knife. It just about sunk Air Canada. I doubt there would be any tax breaks or other concessions here...the Federal Government appears to have washed its hands of this sector.  Far too many growing licenses have been issued by Health Canada.  Over supply is an issue; so unfortunately, a few of these LPs are going to fail.  I just do not see the facilities being worth it.  APHA is having a tough enough time getting A1 and DD functioning at capacity.  The ECOE seems to have fallen completely by the wayside.  I am not a CEO (and those were some great posts regarding us armchair CEOs calling the plays from the sideline, point taken) but I am not sure it is worthwhile buying the whole of ACB when it is likely pieces of it will be able to be bought for next to nothing after they throw in the towel.  We all get a front row seat tomorrow.  Good times.
 

Sid123 wrote: I'm still not getting all the vapes and pre rolls. I'm suggesting they buy ACB at huge discount as they have a couple of world class facilities and would compliment APHA global expansion long term 


<< Previous
Bullboard Posts
Next >>